Fresenius reported €9.32B in Sales Revenues for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Akzo Nobel AKZA:NA € 2410M 101M
Alcon AG ALC:SW 2.1B 8M
AstraZeneca AZN:LN 9866M 1646M
BASF BAS:GR € 19669M 84M
Bayer BAYN:GR € 9781M 1073M
Beiersdorf BEI:GR 1.88B 60M
Davita Healthcare Partners DVA:US $ 2938.32M 21.81M
DSM DSM:NA € 2080M 119M
E.ON EOAN:GR 15.05B 409M
Essilor EI:FP 4.46B 400M
Fresenius FRE:GR € 9324M 78M
Fresenius Medical Care FME:GR € 4441M 120.83M
Fresenius Medical Care FMS:US $ 4441M 120.83M
Getinge GETIB:SS SK 6306M 281M
Givaudan GIVN:VX 3.37B 272M
GlaxoSmithKline GSK:LN 9077M 985M
GN Store Nord GN:DC DK 3787M 9M
GRIFOLS GRF:SM € 1351.9M 167.16M
Hikma Pharmaceutical HIK:LN 1.22B 7M
Lonza Group LONN:SW 2.54B 1.11B
Merck MRK:GR € 4973M 103M
Novartis NOVN:VX SF 13367M 73M
Philips PHIA:NA € 4156M 74M
RWE RWE:GR € 4805M 1064M
William Demant Holding WDH:DC 9.01B 621M